January 29, 2026 – Abbott introduced new five-year knowledge exhibiting that its neuromodulation therapies, together with its patented BurstDR™ spinal wire stimulation (SCS) waveform and dorsal root ganglion stimulation expertise, can considerably cut back pain-related healthcare visits for individuals with power ache. The info, shared on the North American Neuromodulation Society 2026 Annual Assembly in Las Vegas, underscores Abbott’s continued dedication to advancing patient-centered, long-term options that meet the medical wants and day by day challenges of power ache.

A retrospective evaluation offered at NANS discovered that Abbott’s SCS remedy lowered the variety of pain-related healthcare visits in each the brief and long run, with sufferers decreasing their pain-related care by a mean of 75% after 5 years of SCS use.

Proceed studying